Validation of prognostic factors and survival of patients with multiple myeloma in a real-life autologous stem cell transplantation setting: a Swiss single centre experience

Samaras, Panagiotis; Blickenstorfer, Marcel; Haile, Sarah R; Siciliano, Raffaele Daniele; Petrausch, Ulf; Mischo, Axel; Zweifel, Martin; Honegger, Hanspeter; Schanz, Urs; Stussi, Georg; Taverna, Christian; Bauer, Stefan; Knuth, Alexander; Stenner-Liewen, Frank; Renner, Christoph (2011). Validation of prognostic factors and survival of patients with multiple myeloma in a real-life autologous stem cell transplantation setting: a Swiss single centre experience. Swiss medical weekly, 141, w13203. Muttenz: EMH Schweizerischer Ärzteverlag 10.4414/smw.2011.13203

Full text not available from this repository. (Request a copy)

High-dose chemotherapy with subsequent autologous stem cell transplantation (ASCT) is an important treatment option in younger patients with multiple myeloma (MM). We analysed the outcome of patients treated at our institution outside the clinical trials framework and tried to identify risk factors prognostic for survival.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology

UniBE Contributor:

Zweifel, Martin

ISSN:

1424-7860

Publisher:

EMH Schweizerischer Ärzteverlag

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:20

Last Modified:

05 Dec 2022 14:05

Publisher DOI:

10.4414/smw.2011.13203

PubMed ID:

21630163

Web of Science ID:

000291719400002

URI:

https://boris.unibe.ch/id/eprint/6475 (FactScience: 211442)

Actions (login required)

Edit item Edit item
Provide Feedback